Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma

被引：2
|
作者：
Kumar, Vinay [1 ]
Shukla, Surendra Kumar [2 ]
机构：
[1] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Wexner Med Ctr, Columbus, OH 43210 USA
[2] OU Hlth Stephenson Canc Ctr, Dept Oncol Sci, Oklahoma City, OK 73104 USA
来源：
FRONTIERS IN MOLECULAR BIOSCIENCES | 2023年 / 10卷
关键词：
hepatocellular carcinoma (HCC); immunotherapy; metabolic alterations; gene network; HCC prognosis; liver cancer; CANCER;
D O I：
10.3389/fmolb.2023.1202614
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
    Neureiter, Daniel
    Stintzing, Sebastian
    Kiesslich, Tobias
    Ocker, Matthias
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (25) : 3136 - 3150
  • [32] Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking
    Khan, Shakeel Ahmad
    Lee, Terence Kin Wah
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment
    Yin, Zi
    Ma, Tingting
    Chen, Sheng
    Yu, Min
    CANCER BIOMARKERS, 2023, 36 (03) : 231 - 250
  • [34] Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
    Kudo, Masatoshi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (42) : 6005 - 6017
  • [35] DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma
    Zhao, Junsheng
    Liu, Zhengtao
    Yang, Keda
    Shen, Sijia
    Peng, Jing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma
    Marks, Eric I.
    Yee, Nelson S.
    CURRENT CANCER DRUG TARGETS, 2016, 16 (01) : 53 - 70
  • [37] Diagnostic and prognostic molecular markers in hepatocellular carcinoma
    Minguez, Beatriz
    Lachenmayer, Anja
    DISEASE MARKERS, 2011, 31 (03) : 181 - 190
  • [38] Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy
    Chen, Zhen-Dong
    Luo, Jia-Yuan
    Ye, Yu-Ping
    Dang, Yi-Wu
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (05) : 1210 - +
  • [39] Colorectal Carcinoma Cell Growth Inhibition In Vitro and Identification of Molecular Targets using Molecular Docking
    Zhang, Peng
    Li, Shaowen
    Zhang, Pei
    Sun, Yuanfang
    DOKLADY CHEMISTRY, 2024, 515 (1-2) : 77 - 86
  • [40] Identification of ACSF gene family as therapeutic targets and immune-associated biomarkers in hepatocellular carcinoma
    Zhao, Zijin
    Liu, Miaomiao
    Xu, Zhijie
    Cai, Yuan
    Peng, Bi
    Liang, Qiuju
    Yan, Yuanliang
    Liu, Wei
    Kang, Fanhua
    He, Qingchun
    Hong, Qianhui
    Zhang, Wenqin
    Li, Jianbo
    Peng, Jinwu
    Zeng, Shuangshuang
    AGING-US, 2022, 14 (19): : 7926 - 7940
12345